B2M and Hodgkins lymphoma: For instance, inactivating mutations of the beta-2-microglobulin gene (B2M), which are mostly associated with the nodular sclerosis variant [36], lead to MHC class I molecule expression loss and thus impair the ability of immune effector cells to recognize and interact with cells harboring those mutations [37].